Global Intravenous Iron Drug Market Growth, Size, Share, Industry Report and Forecast 2020-2026
The global intravenous iron drug market is projected to grow at a CAGR of around 7% during the forecast period. Iron plays an important role in the transportation of oxygen throughout the body. The key factors that drive the growth of the global intravenous iron drug industry include the increased prevalence of various disorders such as failures, nephrology, gynecology, gastroenterology, and others. One of the applications of the intravenous iron drug is in the treatment of irritable bowel syndrome (IBS).
To Request a Sample of our Report on Global Intravenous Iron Drug Market: https://www.omrglobal.com/request-sample/intravenous-iron-drug-market
IBS is an intestinal disorder that causes abdominal pain, diarrhea,
bloating, and constipation. According to the American Society of
Gastrointestinal Endoscopy (ASGE), around 7-21% of the general population is
suffering from IBS across the globe. There are few medications available in the
market that offer relief to the disorder. As many as one-third of all patients
with inflammatory bowel disease (IBD) have iron-deficiency anemia (IDA).
Therefore, the high prevalence of IBD or IBS may create an opportunity for the
growth of the global intravenous iron drug market.
A
full Report of Global Intravenous Iron Drug Market is Available at: https://www.omrglobal.com/industry-reports/intravenous-iron-drug-market
·
Ferric
Carboxymaltose
·
Iron
Sucrose
·
Iron
Dextran
·
Others
(Ferric Gluconate)
By Application
·
Oncology
·
Chronic
Kidney Diseases
·
Inflammatory
Bowel Diseases
·
Others
Global Intravenous Iron Drug Market – Segmentation by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
Rest of APAC
Rest of The World
·
Middle
East & Africa
·
Latin
America
Company
Profiles
·
Akebia
Therapeutics, Inc.
·
Allergan
PLC
·
AMAG
Pharmaceuticals, Inc.
·
American
Regent, Inc.
·
AstraZeneca
PLC
·
Bristol-Myers
Squibb Co.
·
Daiichi
Sankyo Co., Ltd.
·
FibroGen
·
Pieris
Pharmaceuticals Inc.
·
Pharmacosmos
Group
·
Rockwell
Medical, Inc.
·
Sanofi
SA
·
Shield
Therapeutics Plc
·
Vifor
Pharma Management Ltd.
Reasons for Buying from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/intravenous-iron-drug-market
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports, consulting
and other research-based services.
For More Information, Visit Orion
Market Research
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment